Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
71 hedge funds and large institutions have $124M invested in Frazier Lifesciences Acquisition Corporation Unit in 2020 Q4 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$15.7M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10.4M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.46M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.74M |
| 5 |
Millennium Management
New York
|
+$5.23M |
Top Sellers
FLACU Hedge Fund Activity: Q4 2020 in Review
71 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q4 2020, worth a combined $124M.
Buyers outnumbered sellers: 71 funds opened new FLACU positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Frazier Management, opening a new position worth an estimated $15.7M.
- 71 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $124M of Frazier Lifesciences Acquisition Corporation Unit stock for Q4 2020.
- 71 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q4 2020 and 0 closed out, a net change of +71 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q4 2020 was Frazier Management, an estimated $15.7M added.
Based on aggregated 13F filings for Q4 2020.